Login/Sign Up
MRP ₹15995.5
(Inclusive of all Taxes)
₹2399.3 Cashback (15%)
Provide Delivery Location
About Luprocan 22.5 mg Combipack Injection
Luprocan 22.5 mg Combipack Injection belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists primarily used to treat prostate cancer and endometriosis. Additionally, it is also used to treat precocious puberty (early puberty) in children. Luprocan 22.5 mg Combipack Injection is used in combination with other medicines to treat anaemia caused by uterine fibroids.
Luprocan 22.5 mg Combipack Injection contains Leuprolide acetate, which is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. It works by inhibiting the synthesis of the natural male hormone, testosterone in men and oestrogen in women. This process of lowering hormone levels can decrease cancer cell growth in prostate cancer and helps treat endometriosis.
Luprocan 22.5 mg Combipack Injection will be administered by a healthcare professional. The common side effects of Luprocan 22.5 mg Combipack Injection include hot flashes, decreased sexual interest, dizziness, headache, nausea, vomiting, diarrhoea, upset stomach and injection site reaction. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Avoid taking Luprocan 22.5 mg Combipack Injection if you are pregnant or breastfeeding. Both women and men using Luprocan 22.5 mg Combipack Injection should use effective contraception. Luprocan 22.5 mg Combipack Injection may affect fertility, hence discuss with your doctor if you have any plans to start a family in the future. Luprocan 22.5 mg Combipack Injection is not recommended for children below two years of age. Luprocan 22.5 mg Combipack Injection may cause dizziness, hence drive only if you are alert.
Uses of Luprocan 22.5 mg Combipack Injection
Have a query?
Directions for Use
Medicinal Benefits
Luprocan 22.5 mg Combipack Injection contains Leuprolide acetate, a gonadotropin-releasing hormone (GnRH) agonist. It treats prostate cancer in men, endometriosis in women and precocious puberty (early puberty) in children. Luprocan 22.5 mg Combipack Injection is a synthetic hormone that acts similar to the GnRH, produced by the hypothalamus gland in the brain. Luprocan 22.5 mg Combipack Injection works by lowering testosterone levels in men that help stop the growth of cancer cells in prostate cancer. Luprocan 22.5 mg Combipack Injection reduces oestrogen (a hormone required for the development and regulation of the female reproductive system and secondary sexual characteristics) levels in women, thus helping in endometriosis.
How Luprocan 22.5 mg Combipack Injection Works
Storage
What if I have taken an overdose of Luprocan 22.5 mg Combipack Injection
Drug Warnings
If you are allergic to Luprocan 22.5 mg Combipack Injection or any other medicines, please tell your doctor. Luprocan 22.5 mg Combipack Injection is not indicated for use in pregnancy and breastfeeding women. If you are using Luprocan 22.5 mg Combipack Injection, make sure to use reliable forms of contraception. Luprocan 22.5 mg Combipack Injection may also affect fertility in men, hence discuss with your doctor if you have any plans to start a family in the future. Luprocan 22.5 mg Combipack Injection is not recommended for children younger than two years of age. If you have a seizure or unusual changes in mood or behaviour, inform your doctor immediately. Before starting Luprocan 22.5 mg Combipack Injection, let your doctor know if you have liver or kidney diseases, heart diseases, recent heart attack, depression, brain tumours, electrolyte imbalance, diabetes, fits, weak bones and high cholesterol levels. Luprocan 22.5 mg Combipack Injection may cause QT prolongation (heart muscle takes longer than normal to recharge between beats) and may affect heart rhythm, hence heart patients should be cautious while taking Luprocan 22.5 mg Combipack Injection. Luprocan 22.5 mg Combipack Injection can make you feel dizzy and affects your mental ability to drive. Do not drive or operate machinery if you are not mentally alert and focused.
Drug-Drug Interactions
Login/Sign Up
Drug-Food Interactions
Login/Sign Up
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Unsafe
You are recommended to avoid alcohol consumption while taking Luprocan 22.5 mg Combipack Injection to avoid unpleasant side-effects. Alcohol intake, along with Luprocan 22.5 mg Combipack Injection, may cause increased dizziness.
Pregnancy
Unsafe
Luprocan 22.5 mg Combipack Injection is a pregnancy category X drug. Luprocan 22.5 mg Combipack Injection should not be used during pregnancy because it causes harm to the fetus (newborn baby). Women of childbearing potential must use an effective method of contraception while taking Luprocan 22.5 mg Combipack Injection. Please consult your doctor if you have any concerns regarding this.
Breast Feeding
Unsafe
Luprocan 22.5 mg Combipack Injection should not be taken during breastfeeding as it passes into the breastmilk and may harm the nursing baby. It is contraindicated in breastfeeding mothers.
Driving
Caution
Luprocan 22.5 mg Combipack Injection causes dizziness and affects your ability to drive. Do not drive or operate machinery if you experience any unmanageable side effects with Luprocan 22.5 mg Combipack Injection.
Liver
Caution
If you have had a history or evidence of any liver-related diseases, please consult the doctor before taking Luprocan 22.5 mg Combipack Injection. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Kidney
Caution
If you have had a history or evidence of any kidney-related diseases, please consult the doctor before taking Luprocan 22.5 mg Combipack Injection. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Children
Caution
Luprocan 22.5 mg Combipack Injection is not recommended in children younger than two years of age and should be used with caution and only if absolutely warranted in children under 12.
Luprocan 22.5 mg Combipack Injection belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists primarily used to treat prostate cancer and endometriosis. It is also used to treat precocious puberty (early puberty) in children and in combination with other medicines to treat anaemia caused by uterine fibroids.
Luprocan 22.5 mg Combipack Injection contains Leuprolide acetate, a synthetic hormone that helps reduce the testosterone and oestrogen hormones in men and women, respectively. This process of lowering hormone levels can decrease cancer cell growth in prostate cancer in men and shrinks endometriosis in women.
Luprocan 22.5 mg Combipack Injection affects the hair, making it thin which further causes loss of hair. Hair reduction possibly happens due to the estrogen lowering effect of Luprocan 22.5 mg Combipack Injection. These effects are not long-lasting and may return after some time. If you have any concerns, contact your doctor for further advice.
Luprocan 22.5 mg Combipack Injection may cause impotence and affect fertility in men. It is advised to speak to your doctor if you plan to have a family in the future before starting Luprocan 22.5 mg Combipack Injection.
Luprocan 22.5 mg Combipack Injection should be used with caution in diabetic patients as it may increase the risk of high blood sugar levels. Therefore, regular monitoring of blood sugar levels is recommended while taking Luprocan 22.5 mg Combipack Injection and inform your doctor if you have diabetes before taking Luprocan 22.5 mg Combipack Injection.
Luprocan 22.5 mg Combipack Injection may worsen your mood disorders like depression. Hence it is advised to use Luprocan 22.5 mg Combipack Injection only when you are free from any kind of mental problems. Please consult your doctor for more information.
Luprocan 22.5 mg Combipack Injection may cause osteoporosis (bone thinning) due to the reduction of estrogen in the body. Regular bone density tests may help you monitor osteoporosis. Contact your doctor if you observe any sign of tendon pain or swelling while taking Luprocan 22.5 mg Combipack Injection.
Luprocan 22.5 mg Combipack Injection is not recommended for patients suffering from heart rhythm problems such as arrhythmia (irregular heartbeat) as it may increase the risk of cardiac disease. Therefore, inform your doctor if you have any heart problems before taking Luprocan 22.5 mg Combipack Injection.
Luprocan 22.5 mg Combipack Injection is not a chemotherapy medication. Luprocan 22.5 mg Combipack Injection belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists primarily used to treat prostate cancer and endometriosis.
Luprocan 22.5 mg Combipack Injection may stop periods because it alters reproductive hormones in females. Additionally, people treated with Luprocan 22.5 mg Combipack Injection may experience menstruation or spotting in the first 2 months. If bleeding persists beyond 2 months, consult your doctor.
Yes, Luprocan 22.5 mg Combipack Injection is a hormonal medicine. Leuprolide acetate is a pregnancy category X drug. It should not be used during pregnancy because it may cause harm to the foetus.
Luprocan 22.5 mg Combipack Injection may increase the risk of high blood sugar levels. Therefore, it should be used with caution in diabetic patients. Consult your doctor if you notice any changes in blood sugar levels.
The common side effects of Luprocan 22.5 mg Combipack Injection include hot flashes, decreased sexual interest, dizziness, headache, nausea, vomiting, diarrhoea, upset stomach, and injection site reaction. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Natco Pharma Ltd
Celon Laboratories Pvt Ltd
Cipla Ltd
Sun Pharmaceutical Industries Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Adley Formulations
Admac Lifesciences(Oncology)
Alkem Laboratories Ltd
Neon Laboratories Ltd
Glenmark Pharmaceuticals Ltd
United Biotech Pvt Ltd
Halsted Pharma Pvt Ltd
Emcure Pharmaceuticals Ltd
Zydus Healthcare Ltd
Zydus Cadila
Samarth Life Sciences Pvt Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
GLS Pharma Ltd
Axiommax Oncology Pvt Ltd
Fresenius Kabi India Pvt Ltd
Hetero Healthcare Pvt Ltd
Torrent Pharmaceuticals Ltd
Pfizer Ltd
Getwell Life Sciences India Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Cadila Healthcare Ltd
Aureate Healthcare
Novartis India Ltd
Therdose Pharma Pvt Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Biochem Pharmaceutical Industries Ltd
Delarc Pharmaceuticals Pvt Ltd
Aimcad Biotech Pvt Ltd
Reliance Formulation Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Zee Laboratories Ltd
Msn Laboratories Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Astra Zeneca Pharma India Ltd
Getwell Oncology Pvt Ltd
Caitlin Oncology
Medaegis Biotek Pvt Ltd
Dabur India Ltd
Del Trade International Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Oncostar Pharma Pvt Ltd
Panacea Biotec Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bhardwaj India Pvt Ltd
Getwell Pharmaceutical Pvt Ltd
Cytogen
Lucien Life Sciences
Symbion Lifescience
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cadila Pharmaceuticals Ltd
Miracalus Pharma Pvt Ltd
Vhb Life Sciences Inc
Allieva Pharma Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Zuvius Lifesciences Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Admac Pharma Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Bruck Pharma Pvt Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Sayre Therapeutics Pvt Ltd
Zuventus Healthcare Ltd
Boehringer Ingelheim India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley Oncology
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd
Hillrock Biotech Pvt Ltd
Janssen Pharmaceuticals Pvt Ltd
Jodas Expoim Pvt Ltd
Mankind Pharma Pvt Ltd
Merck Ltd
Oncobiotek Drugs Pvt Ltd
Pharm Products Pvt Ltd
Rhone Poulenc Rorer India Pvt Ltd